Evidence map›Paper›PMID 40520242›Full record

ArticleJournal of diabetes and metabolic disorders2025

Demographic and metabolic risk factors for non-communicable diseases in Iran: insights from a prospective cohort study.

Shaghayegh Khanmohammadi, Mohammad-Reza Malekpour, Amirhossein Habibzadeh, Nazila Rezaei, Sina Azadnajafabad, Negar Rezaei, Azin Ghamari, Rosa Haghshenas, Yosef Farzi, Shirin Djalalinia and 1 more

Abstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shaghayegh Khanmohammadi *Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad-Reza Malekpour *Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Amirhossein HabibzadehNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Nazila RezaeiNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sina AzadnajafabadNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Negar RezaeiNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Azin GhamariNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Rosa HaghshenasNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Yosef FarziEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Shirin DjalaliniaDevelopment of Research and Technology center, Deputy of Research and Technology Ministry of Health and Medical Education, Tehran, Iran.ORCID 0000-0002-9297-0834
Farshad FarzadfarNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Non-communicable diseases (NCDs) have emerged as a leading global health concern, particularly in low- and middle-income countries This study aims to analyze the effect of demographic and metabolic risk factors, including body mass index (BMI), HbA1c, smoking, and high blood pressure, on the incidence and mortality of cardiovascular diseases (CVDs), metabolic disorders, and cancers. Methods: A prospective cohort study was conducted using data from the Iran Cohort Study (ICS), which followed participants from the 2016 STEPs survey. The cohort included 24,818 individuals, with data collected over three years through structured interviews and healthcare records. Statistical analyses were performed to calculate incidence rates, death rates, and rate ratios (RR) for NCDs based on demographic and risk factors. Results: Males exhibited a higher incidence rate of CVDs (RR 1.22, 95% CI 1.05-1.44), while females showed a higher incidence of cancers (males: RR 0.61, 95% CI 0.41-0.89). Individuals with diabetes had a markedly increased incidence rate of CVDs (RR 4.92, 95% CI 3.88-6.24) and metabolic disorders (RR 28.59, 95% CI 13.52-60.43). Hypertension was associated with a heightened incidence rate across all investigated NCDs, while obesity significantly correlated with increased incidences of CVDs (RR 1.92, 95% CI 1.56-2.38) and cancers (RR 1.78, 95% CI 1.13-2.82). Notably, smoking was linked to increased mortality from CVDs (RR 1.63, 95% CI 1.23-2.17). Conclusion: Modifiable risk factors like smoking, high blood pressure, and high BMI, and non-modifiable risk factors like age and sex have significant effect on the burden of NCDs in Iran.

Indexed as

CohortIranNon-communicable diseasesPopulation surveillanceRisk factorsSTEPs

Identifiers

PMID40520242
PMCPMC12158881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.